Cleared Traditional

K222219 - R2 Studio Q/RCT820 (FDA 510(k) Clearance)

Dec 2022
Decision
134d
Days
Class 2
Risk

K222219 is an FDA 510(k) clearance for the R2 Studio Q/RCT820. This device is classified as a X-ray, Tomography, Computed, Dental (Class II - Special Controls, product code OAS).

Submitted by Megagen Implant Co., Ltd. (Daegu, KR). The FDA issued a Cleared decision on December 6, 2022, 134 days after receiving the submission on July 25, 2022.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.1750. Produce Cross-sectional Diagnostic X-ray Images Of The Intra-oral Tissue And Teeth..

Submission Details

510(k) Number K222219 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2022
Decision Date December 06, 2022
Days to Decision 134 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code OAS — X-ray, Tomography, Computed, Dental
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1750
Definition Produce Cross-sectional Diagnostic X-ray Images Of The Intra-oral Tissue And Teeth.